# Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

> **NCT00375934** · PHASE3 · COMPLETED · sponsor: **Xanodyne Pharmaceuticals** · enrollment: 200 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** diclofenac potassium (XP21L)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00375934
- **Lead sponsor:** Xanodyne Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2010-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375934, "Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00375934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*